Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-018745

Chief Medical Officer acquired 22,894 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BALDO LANCE Chief Medical Officer 2021-03-04 Grant or award +22,894 22,894 D
Derivatives
BALDO LANCE Chief Medical Officer 2021-03-04 Grant or award · Stock Option (Right to Buy) +57,234 57,234 D
Loading xslF345X03/doc4.xml…